Patients of doctor’s surgeries, pharmacies and hospitals, participating in the research project with unspecified diseases.
Conditions
Interventions
Group 1: Phase I (1st-8th month): In the first two weeks of the first trial phase the participating doctor's surgeries and pharmacies will be traines in using standard operating procedures for the fol
Sponsors
Klinikum Fürth Zentrale Notaufnahme (ZNA)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Stage 1: Anonymous data collection by using of medication plans: - Written informed consent by patient or his legal representative - Patient takes actually at least 5 medications Stage 2: patient interview: - At least 5 contacts with primary health care providers per year - Patient takes actually at least 5 medications - able to give consent - Written informed consent
Exclusion criteria
Exclusion criteria: Patient under 18 years. Stage 2: Patient interview: not able to give consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the federal patient oriented medication plan with respect to user acceptance, practicability and application of medication plans from the viewpoints of patients and health care providers (physicians, pharmacists and their assistants). | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the federal patient oriented medication plan with respect to completeness and usability for improving medication safety and identification of medication risks. | — |
Countries
Germany
Contacts
Public ContactSusanne Schuster
Klinikum Fürth Zentrale Notaufnahme (ZNA)
Outcome results
None listed